L
Lanlan Shen
Researcher at University of Texas MD Anderson Cancer Center
Publications - 1
Citations - 1419
Lanlan Shen is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Hypomethylating agent & Azacitidine. The author has an hindex of 1, co-authored 1 publications receiving 1312 citations.
Papers
More filters
Journal ArticleDOI
Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study.
Hagop Kantarjian,J. Issa,Craig S. Rosenfeld,John M. Bennett,Maher Albitar,John DiPersio,Virginia Klimek,James Slack,Carlos de Castro,Farhad Ravandi,Richard Helmer,Lanlan Shen,Stephen D. Nimer,Richard Leavitt,Azra Raza,Hussain Saba +15 more
TL;DR: Aberrant DNA methylation, which results in leukemogenesis, is frequent in patients with myelodysplastic syndromes (MDS) and is a potential target for pharmacologic therapy.